Product Information
TEMOZOLOMIDE 250 MG CAPSULE is a generic product labeled by Devatis Inc., priced at $20.5332 per EA under NDC 73043001605. Its NADAC has been published 49 times since Jul 23, 2025.
Strength
250 mg/1
Manufacturer
Devatis Inc.NDC
73043001605
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
10/22/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207658On Market Since
4/28/2017
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 250 MG CAPSULE has been published 49 times since Jul 23, 2025, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.5332 per EA |
|---|---|
| All-time high | $23.2652 (Aug 13, 2025) |
| All-time low | $20.5332 (Oct 22, 2025) |
| 52-week high | $23.2652 |
| 52-week low | $20.5332 |
| Median price | $20.5332 |
| Average price | $21.0071 |
| Largest weekly change | -6.2% (Oct 22, 2025) |
| Weeks tracked | 49 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 250 MG CAPSULE, manufactured by Devatis Inc., is $20.5332 per EA (NDC 73043001605), effective Jun 24, 2026.
How has the price of TEMOZOLOMIDE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 250 MG CAPSULE has declined 11.7%. It has been tracked across 49 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 250 MG CAPSULE?
Since Jul 23, 2025, the NADAC for TEMOZOLOMIDE 250 MG CAPSULE has ranged from a low of $20.5332 (Oct 22, 2025) to a high of $23.2652 (Aug 13, 2025), with a median of $20.5332 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 250 MG CAPSULE?
5 NADAC-published products share the same active ingredient, strength, and dosage form as TEMOZOLOMIDE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMOZOLOMIDE 250 MG CAPSULE?
TEMOZOLOMIDE 250 MG CAPSULE (NDC 73043001605) is labeled by Devatis Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification